Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapy.

Autor: Vanoli F; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Herviou L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tsuda Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sung P; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xie Z; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fishinevich E; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Min SS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mallen W; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., de Wardin HT; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhang Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jasin M; Developmental Biology Program, Sloan Kettering Institute, New York, NY, USA., Antonescu CR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. antonesc@mskcc.org.

Publikováno v: Oncogenesis [Oncogenesis] 2023 Feb 17; Vol. 12 (1), pp. 8. Date of Electronic Publication: 2023 Feb 17.